Arch Therapeutics Announces Positive Outcome of Ruling from Japanese Intellectual Property High Court FRAMINGHAM, Mass., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, is...

Arch Therapeutics Announces Submission of CE Mark File for AC5™ Topical Hemostat in Europe FRAMINGHAM, Mass., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel liquid, gel and solid hemostatic and wound care devices,...

Infusion Therapy Devices Market to Rise Ahead Due to Global Increase in Elderly Population – IndustryARC Research Hyderabad, India, March 11, 2017 (GLOBE NEWSWIRE) -- The report “Infusion Therapy Devices Market: By Type(Infusion Method, Operation Type, Infusion Type) By Types of Infusion Pumps (Large Volume...

Sunshine Heart Announces Strategic Acquisition of Aquadex Product Line from Baxter and a new credit facility with Silicon Valley Bank EDEN PRAIRIE, Minn., Aug. 08, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) announced it has acquired the Aquadex product line from an indirect subsidiary of Baxter International Inc....